Turn Therapeutics (TTRX) Prepaid Assets (2024 - 2026)
Turn Therapeutics (TTRX) posted quarterly Prepaid Assets of $235171.0 for Q1 2026, up 95.49% quarter-over-quarter from $120300.0 in Q4 2025.
Analysis
Turn Therapeutics (TTRX) Prepaid Assets (2024 - 2026) Analysis & Trends
Turn Therapeutics' Prepaid Assets history runs 3 years deep, the most recent figure standing at $235171.0 for Q1 2026.
- In Q1 2026, Prepaid Assets changed N/A year-over-year to $235171.0; the TTM figure through Mar 2026 stood at $235171.0 (changed N/A YoY), while the FY2025 annual figure was $120300.0, down 46.61% from the prior year.
- Prepaid Assets for Q1 2026 stood at $235171.0, up from $120300.0 in the prior quarter.
- The five-year high for Prepaid Assets was $235171.0 in Q1 2026, with the low at $120300.0 in Q4 2025.
- The 3-year median for Prepaid Assets is $206954.0 (2024), against an average of $192344.8.
- Peak annual rise in Prepaid Assets reached 46.61% in 2025, while the deepest fall reached 46.61% in 2025.
- Turn Therapeutics' Prepaid Assets stood at $225325.0 in 2024, then slumped by 46.61% to $120300.0 in 2025, then soared by 95.49% to $235171.0 in 2026.
- Business Quant data shows TTRX's Prepaid Assets at $235171.0 in Q1 2026, $120300.0 in Q4 2025, and $188583.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Turn Therapeutics | 302.05 Mn | 302.05 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 139,688.00 |
| Mar 31, 2026 | 235,171.00 |
| Dec 31, 2025 | 120,300.00 |
| Sep 30, 2025 | 188,583.00 |
| Dec 31, 2024 | 225,325.00 |